TRIMEL PHARMACEUTICALS
Trimel Pharmaceuticals Corporation, a specialty pharmaceutical company, engages in developing medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders. Its product pipeline includes CompleoTRT, a bioadhesive intranasal gel formulation of testosterone, which has completed Phase III clinical study for treating male hypogonadism; Tefina, an intranasal low-dose gel formulation of testosterone, which is in Phase II clinical study for treating female sexual dysfu... nction; TBS-3, an intranasal gel formulation of dopamine that has completed a preclinical study for the treatment of Parkinson’s disease; and TBS-7 for the prevention and treatment of asthma symptoms. Its products also include TBS-5, which is in the formulation development stage for the long-term treatment of airway inflammation caused by asthma; and TBS-6, which is in the early-stage exploratory development stage for the treatment of allergic rhinitis. The company was founded in 2008 and is headquartered in Mississauga, Canada.
TRIMEL PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Mississauga, Ontario, Canada
Country:
Canada
Website Url:
http://www.trimelpharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
416-679-0771
Email Addresses:
[email protected]
Total Funding:
69.92 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
First Generation Capital
First Generation Capital investment in Post-IPO Equity - Trimel Pharmaceuticals
West Face Capital
West Face Capital investment in Post-IPO Equity - Trimel Pharmaceuticals
Official Site Inspections
http://www.trimelpharmaceuticals.com
Unable to get host informations!!!
More informations about "Trimel Pharmaceuticals"
Trimel Pharmaceuticals Corporation Information
The NAICS codes for Trimel Pharmaceuticals Corporation are [32, 62151, 325, 32541, 3254, 6215, 621, 62]. What is the SIC code for Trimel Pharmaceuticals Corporation? The SIC codes …See details»
Trimel Pharmaceutica (TRLPF) Profile - The Globe and Mail
See the company profile for Trimel Pharmaceutica (TRLPF) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Trimel Pharmaceuticals Corp - Drug pipelines, Patents, Clinical …
Explore Trimel Pharmaceuticals Corp with its drug pipeline, therapeutic area, technology platform, .See details»
Trimel Pharmaceuticals - Funding, Financials, Valuation & Investors
Trimel Pharmaceuticals develops medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders. Search Crunchbase. Start Free Trial . ... How much funding …See details»
Trimel Pharmaceuticals Announces Positive Phase II Results
May 28, 2014 Trimel Pharmaceuticals Announces Positive Phase II Results for Tefina™ ... Organization Profile. Trimel Pharmaceuticals Corporation. Contact Cision. 866-245-2317 from …See details»
Trimel Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Trimel Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Trimel Pharmaceutica (TRLPF) Stock Price and News
Real-time Price Updates for Trimel Pharmaceutica (TRLPF), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Trimel Pharmaceuticals Corporation Completes $40 Million Equity ...
Apr 24, 2013 Trimel Pharmaceuticals Corporation (TSX:TRL) (the “Company” or “Trimel”) is pleased to announce that it has completed its previously announced public offering (the …See details»
Trimel Provides Clinical and Operational Update - Yahoo Finance
Oct 15, 2012 Trimel Pharmaceuticals Corporation today announced progress on three of its product candidates:See details»
Trimel Enters Into TriVair(TM) Development Agreement - Yahoo …
Mar 19, 2013 Trimel Pharmaceuticals Corporation - Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction …See details»
Trimel Pharmaceuticals Corporation Announces Changes to Equity …
Apr 3, 2013 Trimel Pharmaceuticals Corporation (the "Company" or "Trimel") announced today that it has filed an amended and restated preliminary short form prospectus (the "Amended …See details»
Trimel Pharmaceuticals - Crunchbase
Trimel Pharmaceuticals develops medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders. Search Crunchbase Start Free TrialSee details»
Trimel Pharmaceuticals Corporation Completes $40 Million Equity …
Apr 24, 2013 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Trimel Pharmaceuticals Corporation is pleased to …See details»
The world’s largest medicine cabinet—and so much more. - Teva …
At Teva, we care deeply about the wellbeing of the patients, caregivers and communities who rely on us. We serve 200 million people every day, with a promise to help them take better control …See details»
TBS 5 - AdisInsight - Springer
May 17, 2016 08 Sep 2015 Trimel Pharmaceuticals is now called Acerus Pharmaceuticals 04 Mar 2015 Preclinical development is ongoing in Canada ... If your organization has a …See details»
Impres Pharma Inc. Information - RocketReach
Impres Pharma is recognized as Canada's premier healthcare-focused contract sales organization (CSO). We have earned this position by driving exceptional sales growth through …See details»
Trimel Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Trimel Pharmaceuticals uses 3 technology products and services including HTML5, Microsoft Outlook, and Office 365, according to G2 Stack. Trimel Pharmaceuticals is actively using 2 …See details»
Trimel Receives FDA Approval for Natesto™ Nasal Gel to
May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto™...See details»
Trimel Pharmaceuticals Acquires Canadian Rights to Estrace®
Jul 17, 2014 TORONTO, ONTARIO--(Marketwired - July 17, 2014) - Trimel Pharmaceuticals Corporation is pleased to announce that it has acquired from Shire plc, the Canadian rights for …See details»